Drug Safety Panel Is Criticized

Yet again this administration has put the FOX in charge of guarding the Henhouse.

The new drug safety board established by the Food and Drug Administration to restore confidence in the nation’s drug supply will actually set back efforts to improve the safety of the medications Americans take and will not make it any easier to take dangerous drugs off the market, an FDA whistle-blower and a key senator said.

FDA safety officer David Graham said that after reviewing the makeup and structure of the Drug Safety Oversight Board, he concluded that the panel is “severely biased in favor of industry” and that “the FDA cannot be trusted to protect the public or reform itself.”